Flu News and Research

RSS

U.K. doctors test lipid ibuprofen as COVID-19 treatment

The non-steroidal anti-inflammatory drug (NSAID) Ibuprofen is being tested as a potential treatment for the coronavirus disease (COVID-19). Doctors in the United Kingdom rolled out a clinical trial of the everyday painkiller to see if it reduces respiratory failure in patients experiencing severe COVID-19 disease.

4 Jun 2020

KHN’s ‘What the Health?’: Protests and the pandemic

Following the death of George Floyd while in custody in Minneapolis, protests have mushroomed around the U.S. to decry police violence, raising concerns among public health officials about the potential for further spread of the coronavirus.

4 Jun 2020

Drug Teixobactin shows promise against drug-resistant superbugs

Two well-known superbugs are the gram-positive methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE). A new drug Teixobactin has shown promise against these microbes. The study titled, “The Killing Mechanism of Teixobactin against Methicillin-Resistant Staphylococcus aureus: an Untargeted Metabolomics Study,” was published in the latest issue of the journal Therapeutics and Prevention.

4 Jun 2020

Chapman University survey highlights effects of COVID-19 on physical and mental health

The Chapman University National COVID-19 and Mental Health Survey provides an in-depth look at the experiences of 4,149 adults living in the United States.

3 Jun 2020

Tumors cause disruption of the immune system throughout the body, study finds

Cancer treatment has advanced with the advent of immunotherapies that, in some cancers, can overcome tumors' ability to evade the immune system by suppressing local immune responses.

3 Jun 2020

A tailored public health approach could guide the next phase of COVID-19 pandemic

A tailored public health approach that accounts for variation in risks across populations, places and time could guide the next phase of Canada's coronavirus disease 2019 (COVID-19) response, argue authors in a commentary in CMAJ.

3 Jun 2020

Convalescent plasma therapy improves outcomes in majority of COVID-19 patients

First peer-reviewed publication on US trial results from Houston Methodist published in The American Journal of Pathology

3 Jun 2020

A vectored vaccine candidate against SARS-CoV-2

The current pandemic of COVID-19 is caused by the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), a betacoronavirus similar to that which caused the SARS-CoV and MERS-CoV earlier. Scientists are pursuing therapeutic drugs and vaccines to counter the relentless spread of the virus, but so far, none has been established to be effective. However, several are in clinical trials in various parts of the world.

2 Jun 2020

Approach used against influenza epidemics could benefit COVID-19 drug development

A new study from researchers at The University of Texas at Austin has found that some antivirals are useful for more than helping sick people get better -- they also can prevent thousands of deaths and hundreds of thousands of virus cases if used in the early stages of infection.

2 Jun 2020

Could the next pandemic be 100 times worse than COVID-19?

As the world tries to cope with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes coronavirus disease (COVID-19), Dr. Michael Herschel Greger has claimed that worse could be yet to come. The American nutrition expert has claimed in his latest book that the next pandemic could be due to virus emanating from poultry farms.

2 Jun 2020

COVID-19 mortality is significantly higher in hospitalized patients with diabetes

A new meta-analysis published on the preprint server medRxiv by the researchers from the United States and Greece reveals that the likelihood of death is 65% higher in hospitalized coronavirus disease (COVID-19) patients with diabetes when compared to non-diabetics – urging the adequate glucose control in the era of the pandemic.

31 May 2020

When flu season converges with COVID-19

As if the COVID-19 pandemic isn't scary enough, the flu season is not far away. How severe will the flu season be as it converges with the COVID-19 outbreak? What can we do to prepare?

30 May 2020

Older men exhibit less COVID-19 worries than others

Older men may be at greater risk of contracting COVID-19 because they worry less about catching or dying from it than women their age or than younger people of both sexes, according to a new study by Sarah Barber, a gerontology and psychology researcher at Georgia State University.

29 May 2020

Is air pollution a risk factor for COVID-19 infection?

The COVID-19 pandemic began at the very end of 2019 in Wuhan city, Hubei province, China. However, its spread soon began to threaten the health of the whole country and then of the world, leading to nearly 5.7 million cases and over 355,000 dead as of today. A new study, published on the preprint server medRxiv* in May 2020, explores the effects of air pollution on COVID-19 infections in China.

27 May 2020

Blood clotting disorders may explain some of the worst symptoms of COVID-19

The hypothesis that blood clotting disorders may explain some of the worst symptoms of COVID-19, including respiratory failure and pulmonary fibrosis, was suggested in mid-April by researchers in Brazil affiliated with the University of São Paulo's Medical School (FM-USP) via an article accepted for publication by the Journal of Thrombosis.

27 May 2020

Flu News and Research

U.K. doctors test lipid ibuprofen as COVID-19 treatment

KHN’s ‘What the Health?’: Protests and the pandemic

Drug Teixobactin shows promise against drug-resistant superbugs

Chapman University survey highlights effects of COVID-19 on physical and mental health

Tumors cause disruption of the immune system throughout the body, study finds

A tailored public health approach could guide the next phase of COVID-19 pandemic

Convalescent plasma therapy improves outcomes in majority of COVID-19 patients

A vectored vaccine candidate against SARS-CoV-2

Approach used against influenza epidemics could benefit COVID-19 drug development

Could the next pandemic be 100 times worse than COVID-19?

COVID-19 mortality is significantly higher in hospitalized patients with diabetes

When flu season converges with COVID-19

Older men exhibit less COVID-19 worries than others

Is air pollution a risk factor for COVID-19 infection?

Blood clotting disorders may explain some of the worst symptoms of COVID-19

Researchers to study the ability of optical radiation to disinfect surfaces

HORIBA’s Microsemi CRP helps to keep vulnerable patients away from risk during COVID-19

Challenges of diagnosing Lyme disease in the absence of classic symptoms

Using Qigong to manage COVID-19 in older adults

Study finds evidence of injury in placentas from COVID-19-positive pregnant women

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News